ENTX
Entera Bio Ltd
2.60$
-8.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.1% | +0.0% | -15.4% | +0.0% | +0.0% | -27.3% | -12.5% | +14.3% | -12.5% | +0.0% | +28.6% | – | |
| – | -17.0% | +45.9% | +28.9% | +55.2% | -39.0% | +6.7% | -15.7% | +82.1% | -23.4% | -5.4% | -7.1% | – | |
| – | -313.0% | – | – | -136.9% | – | +88.1% | -12.3% | -136.6% | – | -158.2% | – | – | |
| – | +2,479.0% | -100.0% | – | -75.0% | +299,900.0% | +166.6% | +262.5% | +60.3% | -35.8% | -100.0% | – | – | |
| – | -2,678.2% | – | – | – | – | +166.6% | +262.5% | +60.2% | -35.8% | – | – | – | |
| – | – | -99.5% | +3,953.5% | -98.9% | +24,646.2% | +314.6% | -100.4% | – | -51.8% | -66.4% | +7,560.8% | – | |
| – | – | -151.3% | – | – | – | +581.9% | -114.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.